The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
Open accessAbstract
Tumor angiogenesis is of paramount importance in solid tumor development. Elevated serum levels of YKL-40, which is a secreted heparin-binding glycoprotein, have been associated with a worse prognosis from various advanced human cancers. Yet the role of YKL-40 activity in these cancers is still missing. In this study, we showed that ectopic expression of YKL-40 in MDA-MB-231 breast cancer cells and in HCT-116 colon cancer cells led to larger tumor formation with an extensive angiogenic phenotype than did control cancer cells in mice. Affinity-purified recombinant YKL-40 protein promoted vascular endothelial cell angiogenesis in vitro, the effects of which are similar to the activities observed using MDA-MB-231 and HCT-116 cell-conditioned medium after transfection with YKL-40. Furthermore, YKL-40 was found to induce coordination of membrane-bound receptor syndecan-1 and integrin αvβ3 and to activate an intracellular signaling cascade, including focal adhesion kinase and mitogen-activated protein kinase extracellular signal-related kinase1/2 in endothelial cells. Moreover, blockade of YKL-40 using small-interfering RNA gene knockdown suppressed tumor angiogenesis in vitro and in vivo. Immunohistochemical analysis of human breast cancer showed a correlation between YKL-40 expression and blood vessel density. These findings provide novel insights into angiogenic activities and molecular mechanisms of YKL-40 in cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127
Hakala, B. E., White, C., & Recklies, A. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74461-5 · Cited by 646
A public database for gene expression in human cancers.
Lal, A., Lash, A., Altschul, S. F., Velculescu, V. E., Zhang, L., McLendon, R. E., Marra, M. A., Prange, C. K., Morin, P. J., Polyák, K., et al. (1999) · PubMed · Cited by 414
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413
Renkema, G. H., Boot, R. G., Au, F. L., Donker‐Koopman, W. E., Strijland, A., Muijsers, A. O., Hrebicek, M., & Aerts, J. M. F. G. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510504.x · Cited by 402
RECKLIES, A. D., WHITE, C., & LING, H. (2002) · Biochemical Journal · doi:10.1042/bj20020075 · Cited by 388
Fahmy, R. G., Dass, C. R., Sun, L.-Q., Chesterman, C. N., & Khachigian, L. M. (2003) · Nature Medicine · doi:10.1038/nm905 · Cited by 361
Nigro, J. M., Misra, A., Zhang, L., Smirnov, I., Colman, H., Griffin, C., Ozburn, N., Chen, M., Pan, E., Koul, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2921 · Cited by 325
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O. N., Alitalo, K. K., Vecchio, S. D., Lei, K. J., Chou, J. Y., & Persico, M. G. (1993) · PubMed · Cited by 313
Identification of proteins secreted by human osteoblastic cells in culture
Johansen, J. S., Williamson, M. K., Rice, J. S., & Price, P. A. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070506 · Cited by 269
Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
Hood, J. D., Frausto, R., Kiosses, W. B., Schwartz, M. A., & Cheresh, D. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304105 · Cited by 262
Serum YKL-40 is increased in patients with hepatic fibrosis
Johansen, J. S., Christoffersen, P., Møller, S., Price, P. A., Henriksen, J. H., Garbarsch, C., & Bendtsen, F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80095-1 · Cited by 252
Crystal Structure and Carbohydrate-binding Properties of the Human Cartilage Glycoprotein-39
Fusetti, F., Pijning, T., Kalk, K. H., Bos, E., & Dijkstra, B. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303137200 · Cited by 235
The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells
Beauvais, D. M., Burbach, B. J., & Rapraeger, A. C. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404171 · Cited by 234
Shackelton, L. M., Mann, D. M., & Millis, A. J. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13076 · Cited by 218
Jensen, B. V., Johansen, J. S., & Price, P. A. (2003) · PubMed · Cited by 209
Pelloski, C. E., Mahajan, A., Maor, M., Chang, E. L., Woo, S., Gilbert, M., Colman, H., Yang, H., Ledoux, A., Blair, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1765 · Cited by 207
Hu, B., Trinh, K., Figueira, W. F., & Price, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19415 · Cited by 201
Hormigo, A., Gu, B., Karimi, S., Riedel, E., Panageas, K. S., Edgar, M. A., Tanwar, M. K., Rao, J. S., Fleisher, M., DeAngelis, L. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0181 · Cited by 182
Yan, W., & Shao, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601856200 · Cited by 169
Self-citationBeauvais, D. M., & Rapraeger, A. C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00126-5 · Cited by 150
Clusterin plays an important role in hepatocellular carcinoma metastasis
Lau, S. H., Sham, J. S. T., Xie, D., Tzang, C.-H., Tang, D., Ma, N., Hu, L., Wang, Y., Wen, J.-M., Xiao, G., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209141 · Cited by 149
High serum YKL‐40 level after surgery for colorectal carcinoma is related to short survival
Cintin, C., Johansen, J. S., Christensen, I. J., Price, P. A., Sørensen, S., & Nielsen, H. J. (2002) · Cancer · doi:10.1002/cncr.10644 · Cited by 137
Polnaszek, N., Kwabi‐Addo, B., Peterson, L. E., Özen, M., Greenberg, N. M., Ortega, S., Basilico, C., & Ittmann, M. (2003) · PubMed · Cited by 134
High serum YKL-40 level in patients with small cell lung cancer is related to early death
Johansen, J. S. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.010 · Cited by 133
Nyirkos, P., & Golds, E. E. (1990) · Biochemical Journal · doi:10.1042/bj2690265 · Cited by 122
Schmidt, H., Johansen, J. S., Gehl, J., Geertsen, P. F., Fode, K., & von der Maase, H. (2006) · Cancer · doi:10.1002/cncr.21678 · Cited by 122
Brasso, K., Christensen, I. J., Johansen, J. S., Teisner, B., Garnero, P., Price, P. A., & Iversen, P. (2005) · The Prostate · doi:10.1002/pros.20311 · Cited by 116
Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology
Jendraschak, E., & Sage, E. H. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0019 · Cited by 113
Naruse, T., Nishida, Y., Hosono, K., & Ishiguro, N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi240 · Cited by 111
Syndecan-1 regulates αvβ5 integrin activity in B82L fibroblasts
McQuade, K. J., Beauvais, D. M., Burbach, B. J., & Rapraeger, A. C. (2006) · Journal of Cell Science · doi:10.1242/jcs.02970 · Cited by 108
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival
Høgdall, E. V. S., Johansen, J. S., Kjær, S. K., Price, P., Christensen, L. H., Blaakær, J., Bock, J. E., Glud, E., & Høgdall, C. K. (2003) · Oncology Reports · doi:10.3892/or.10.5.1535 · Cited by 89
Bergmann, O. J., Johansen, J. S., Klausen, T. W., Mylin, A. K., Kristensen, J. S., Kjeldsen, E., & Johnsen, H. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1317 · Cited by 78
Sharif, M., Granell, R., Johansen, J. S., Clarke, S., Elson, C. J., & Kirwan, J. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/kei216 · Cited by 46
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer
Roslind, A., Knoop, A. S., Jensen, M., Johansen, J. S., Nielsen, D. L., Price, P. A., & Balslev, E. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9870-7 · Cited by 36
Cited by
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Lee, C. G., Da Silva, C. A., Dela Cruz, C. S., Ahangari, F., Ma, B., Kang, M.-J., He, C.-H., Takyar, S., & Elias, J. A. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142250 · Cited by 896
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
Pereira, J. B., Janelidze, S., Smith, R., Mattsson-Carlgren, N., Palmqvist, S., Teunissen, C. E., Zetterberg, H., Stomrud, E., Ashton, N. J., Blennow, K., et al. (2021) · Brain · doi:10.1093/brain/awab223 · Cited by 598
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Chitinase-3 like-protein-1 function and its role in diseases
Zhao, T., Su, Z., Li, Y., Zhang, X., & You, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00303-7 · Cited by 536
Metadata
- Authors
- Shao, R., Hamel, K., Petersen, L., Cao, Q. J., Arenas, R. B., Bigelow, C., Bentley, B., & Yan, W.
- Venue
- Oncogene
- Published
- 2009-09-21
- Volume
- 28
- Issue
- 50
- Pages
- 4456-4468
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2027072680
- Cited by
- 292
- References
- 40
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.